SGI-DNA: Brian Donnelly

Synthetic biology firm SGI-DNA announced the appointment of Brian Donnelly to the newly created position of chief commercial officer. Donnelly will be responsible for global sales, marketing, customer service and support, and business development.

Donnelly comes to the firm from Illumina, where he most recently led Illumina's global service organization. During his time at Illumina, Brian also led the global commercial strategy and global clinical marketing teams. He has also held commercial and operational roles at Sequenom, GlaxoSmithKline, and Allergan. He holds MBA and JD degrees from Rutgers University.